CN101442958B - Apparatus for cardiac valve replacement - Google Patents

Apparatus for cardiac valve replacement Download PDF

Info

Publication number
CN101442958B
CN101442958B CN2007800173920A CN200780017392A CN101442958B CN 101442958 B CN101442958 B CN 101442958B CN 2007800173920 A CN2007800173920 A CN 2007800173920A CN 200780017392 A CN200780017392 A CN 200780017392A CN 101442958 B CN101442958 B CN 101442958B
Authority
CN
China
Prior art keywords
wall
adapter
valve
balloon
stent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2007800173920A
Other languages
Chinese (zh)
Other versions
CN101442958A (en
Inventor
T·R·瑞安
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medtronic Inc
Original Assignee
Medtronic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtronic Inc filed Critical Medtronic Inc
Publication of CN101442958A publication Critical patent/CN101442958A/en
Application granted granted Critical
Publication of CN101442958B publication Critical patent/CN101442958B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2418Scaffolds therefor, e.g. support stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2427Devices for manipulating or deploying heart valves during implantation
    • A61F2/243Deployment by mechanical expansion
    • A61F2/2433Deployment by mechanical expansion using balloon catheter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2427Devices for manipulating or deploying heart valves during implantation
    • A61F2/2436Deployment by retracting a sheath
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0069Three-dimensional shapes cylindrical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0003Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having an inflatable pocket filled with fluid, e.g. liquid or gas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0004Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable
    • A61F2250/001Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable for adjusting a diameter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0039Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in diameter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/006Additional features; Implant or prostheses properties not otherwise provided for modular

Landscapes

  • Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mechanical Engineering (AREA)
  • Prostheses (AREA)

Abstract

一种放置瓣膜于管状器官内的方法,该方法包括输送可扩张管状适配器至管状器官内的期望部位,其中适配器包括由与内壁隔开的外壁环绕的封闭容积以及第一端壁和第二端壁。该方法还包括相对于内壁扩张外壁使得外壁接触管状器官并放置瓣膜于适配器的内壁内。该方法还包括置入材料于适配器的封闭容积内以相对于内壁扩张外壁,其中材料可包括液体或凝胶。或者,瓣膜可在适配器输送至期望部位前置于内壁内。

Figure 200780017392

A method of placing a valve within a tubular organ, the method comprising delivering an expandable tubular adapter to a desired location within the tubular organ, wherein the adapter includes an enclosed volume surrounded by an outer wall spaced from an inner wall, and a first end wall and a second end wall. The method also includes expanding the outer wall relative to the inner wall such that the outer wall contacts the tubular organ and positioning the valve within the inner wall of the adapter. The method also includes placing a material within the enclosed volume of the adapter to expand the outer wall relative to the inner wall, where the material may include a liquid or a gel. Alternatively, the valve may be placed within the inner wall prior to delivery of the adapter to the desired site.

Figure 200780017392

Description

心脏瓣膜替换设备Heart Valve Replacement Devices

技术领域 technical field

本发明一般地涉及心脏瓣膜疾病的治疗,并且更具体地,涉及机能失常肺动脉瓣膜的替换。The present invention relates generally to the treatment of heart valve disease and, more particularly, to the replacement of malfunctioning pulmonary valves.

背景技术 Background technique

近年来,人们越来越关注心脏瓣膜的微创和经皮替换。在肺动脉瓣膜替换这一具体情况下,由Tower等人提交且全文结合于此以供参考的美国专利申请公开No.2003/0199971 A1和No.2003/0199963 A1说明了安装于可伸缩支架内用作替换肺动脉瓣膜的带瓣牛颈静脉段。该替换瓣膜安装于球囊导管中并经血管系统经皮送至失常肺动脉瓣膜位置,并由球囊扩张以压缩自体瓣膜小叶抵住右心室流出道,锚定并密封替换瓣膜。如论文《肺动脉瓣膜的经皮置入》(Percutaneous Insertion of the Pulmonary Valve),Bonhoeffer等人,《美国心脏病学会杂志》(Journal of the American College of Cardiology)2002;39:1664-1669和《牛肺动脉瓣膜的经导管替换》(Transcatheter Replacementof a Bovine Valve in Pulmonary Position),Bonhoeffer等人,《循环》(Circulation)2000;102:813-816所述,其全文结合于此以供参考,可植入替换肺动脉瓣膜以替换位于带瓣导管内的自体肺动脉瓣膜或人工肺动脉瓣膜。说明经皮瓣膜移植特点的其它论文包括Louise Coats等人的《经皮肺动脉瓣膜支架移植对右心室流出道再次介入的潜在影响》(The Potential Impactof Percutaneous Pulmonary Valve Stent Implantation on Right VentricularOutflow Tract Re-Intervention),《欧洲心胸外科杂志(英国)》(EuropeanJournal of Cardio-Thoracic Surgery(England)),2005年4月,第536-43页;Peter C.Block等人的《心脏瓣膜疾病的经皮研究法》(PercutaneousApproaches to Valvular Heard Disease),《最新心脏学报告(美国)》(CurrentCardiology Reports(United States)),2005年3月,第108-13页;GeorgLutter等人的《经皮瓣膜替换:最新状况和未来展望》(Percutaneous ValveReplacement:Current State and Future Prospects),《胸外科纪事(荷兰)》(Annals of Thoracic Surgery(Netherlands)),2004年12月,第2199-206页;Younes Boudjemline等人,《较大右心室流出道内的经皮肺动脉瓣膜替换:实验研究》(Percutaneous Pulmonary Valve Replacement in a Large RightVentricular Outflow Tract:An Experimental Study),《美国心脏病学会杂志(美国)》(Journal of the American College of Cardiology(UnitedStates)),2004年3月17日,第1082-7页;S.Khambadkone等人,《肺动脉瓣膜的经皮移植》(Percutaneous Implantation of Pulmonary Valyes),《心血管病治疗专家评论(英国)》(Expert Review of Cardiovascular Therapy(England)),2003年11月,第541-18页;Y.Boudjemline等人,《经皮瓣膜置入:一种新方法》(Percutaneous Valve Insertion:A New Approach),《胸和心血管外科杂志(美国)》(Journal of Thoracic and CardiovascularSurgery(United States)),2003年3月,第741-2页;Philipp Bonhoeffer等人,《肺动脉瓣膜的经皮置入》(Percutaneous Insertion of the PulmonaryValye),《美国心脏病学会杂志(美国)》(Journal of the American Collegeof Cardiology(United States)),2002年5月15日,第1664-9页;YounesBoudjemline等人,《走近经皮主动脉瓣膜替换》(Steps Toward PercutaneousAortic Valve Replacement),《循环(美国)》(Circulation(United States)),2002年2月12日,第775-8页;P.Bonhoeffer等人,《瓣膜机能失常的右心室至肺动脉人工导管内肺动脉瓣膜的经皮替换》(PercutaneousReplacement of Pulmonary Valve in a Right-Ventricle to Pulmonary-ArteryProsthetic Conduit with Valve Dysfunction),《柳叶刀(英国)》(Lancet(England)),2000年10月21日,第1403-5页;P.Bonhoeffer等人,《牛肺动脉瓣膜的经导管移植:羊羔实验》(Transcatheter Implantation of aBovine Valve in Pulmonary Position:A Lamb Study),《循环(美国)》(Circulation(United States)),2000年8月15日,第813-6页;G.O.Yonga等人,《经皮球囊二尖瓣分离术对重度二尖瓣狭窄的肺静脉血流的影响》(Effect of Percutaneous Balloon Mitral Valvotomy on Pulmonary VenousFlow in Severe Mitral Stenosis),《东非医学杂志(肯尼亚)》(East AfricanMedical Journal(Kenya)),1999年1月,第28-30页;以及G.O.Yonga等人,《肺动脉瓣膜狭窄的经皮腔内球囊瓣膜成形术:六个病例报告》(Percutaneous Transluminal Balloon Valvuloplasty for Pulmonary ValveStenosis:Report on Six Cases),《东非医学杂志(肯尼亚)》(East AfricanMedical Journal(Kenya)),1994年4月,第232-5页,其全文均结合于此以供参考。In recent years, there has been increasing focus on minimally invasive and percutaneous replacement of heart valves. In the specific case of pulmonary valve replacement, U.S. Patent Application Publication Nos. 2003/0199971 A1 and 2003/0199963 A1, filed by Tower et al. and incorporated herein by reference in their entirety, describe A valved bovine jugular vein segment used as a replacement for the pulmonary valve. The replacement valve is mounted in a balloon catheter and delivered percutaneously through the vasculature to the site of the aberrant pulmonary valve, where it is expanded by the balloon to compress the native valve leaflets against the right ventricular outflow tract, anchoring and sealing the replacement valve. Such as the paper "Percutaneous Insertion of the Pulmonary Valve", Bonhoeffer et al., "Journal of the American College of Cardiology" (Journal of the American College of Cardiology) 2002; 39: 1664-1669 and "Bovine Transcatheter Replacement of a Bovine Valve in Pulmonary Position, Bonhoeffer et al., Circulation 2000;102:813-816, which is hereby incorporated by reference in its entirety, Implantable Pulmonary valve replacement to replace a native or prosthetic pulmonary valve within a valved catheter. Other papers that characterize percutaneous valve implantation include Louise Coats et al., The Potential Impact of Percutaneous Pulmonary Valve Stent Implantation on Right Ventricular Outflow Tract Re-Intervention ), "European Journal of Cardio-Thoracic Surgery (England)", April 2005, pp. 536-43; Peter C. Block et al. "Percutaneous approach to heart valve disease Percutaneous Approaches to Valvular Heard Disease, Current Cardiology Reports (United States), March 2005, pp. 108-13; Georg Lutter et al. Percutaneous Valve Replacement: Latest Percutaneous Valve Replacement: Current State and Future Prospects, Annals of Thoracic Surgery (Netherlands), December 2004, pp. 2199-206; Younes Boudjemline et al. Percutaneous Pulmonary Valve Replacement in a Large Right Ventricular Outflow Tract: An Experimental Study, Journal of the American College of Cardiology (USA) of Cardiology (United States)), March 17, 2004, pp. 1082-7; S. Khambadkone et al., Percutaneous Implantation of Pulmonary Valyes, Expert Review of Cardiovascular Therapy ( UK) (Expert Review of Cardiovascular Therapy (England)), November 2003, No. 5 pp. 41-18; Y. Boudjemline et al., Percutaneous Valve Insertion: A New Approach, Journal of Thoracic and Cardiovascular Surgery (USA). CardiovascularSurgery (United States)), March 2003, pp. 741-2; Philipp Bonhoeffer et al, "Percutaneous Insertion of the PulmonaryValye", Journal of the American College of Cardiology (USA) (Journal of the American College of Cardiology (United States)), May 15, 2002, pp. 1664-9; YounesBoudjemline et al., Steps Toward Percutaneous Aortic Valve Replacement, Circulation (United States)" (Circulation (United States)), February 12, 2002, pp. 775-8; P. Bonhoeffer et al., "Percutaneous Replacement of Pulmonary Valve in Right Ventricular to Pulmonary Artery Catheters with Valve Dysfunction" (Percutaneous Replacement of Pulmonary Valve in a Right-Ventricle to Pulmonary-Artery Prosthetic Conduit with Valve Dysfunction), "The Lancet (UK)" (Lancet (England)), October 21, 2000, pp. 1403-5; P. Bonhoeffer et al., Transcatheter Implantation of a Bovine Valve in Pulmonary Position: A Lamb Study, Circulation (United States), 15 Aug. 2000 pp. 813-6; G.O. Yonga et al., Effect of Percutaneous Balloon Mitral Valvotomy on Pulmonary Venous Flow in Severe Mitral Stenosis, East African Medical Journal (Kenya), January 1999, pp. 28-30; and G.O. Yonga et al., Percutaneous Endoluminal Balloons for Pulmonary Valve Stenosis Percutaneous Transluminal Balloon Valvuloplasty for Pulmonary ValveStenosis: Report on Six Cases, East African Medical Journal (Kenya), April 1994, pp. 232- 5 pages, the entirety of which is hereby incorporated by reference.

尽管上述专利申请及论文所述的肺动脉瓣膜替换方法似乎是可行的治疗方法,但因可用的带瓣牛颈静脉段的尺寸范围相对较窄,一般仅可用至约22mm的直径,因此并非所有可受益的人均可用。不幸的是,需要肺动脉瓣膜替换的最常见的病人群体为婴儿时期已接受过法洛四联症跨环补片(transannularpatch repair of tetralogy of Fallot)的成年人和儿童,从而使得他们的右心室流出道的直径大于22mm。因此,一般的静脉段通常不能安全植入这些病人体内。Although the pulmonary valve replacement approach described in the aforementioned patent application and paper appears to be a viable treatment, not all available valved bovine jugular vein segments are available in a relatively narrow size range, typically down to a diameter of approximately 22 mm. Available to all beneficiaries. Unfortunately, the most common patient population requiring pulmonary valve replacement is adults and children who have received a transannular patch repair of tetralogy of Fallot as infants, causing their right ventricle to outflow The diameter of the track is greater than 22mm. Therefore, conventional vein segments generally cannot be safely implanted in these patients.

图1示出了已开发的允许带瓣牛颈静脉段用于右心室流出道较大的病人的现有技术的适配器支架10的一个示例。支架10包括由镍钛诺金属丝制成的丝网支架,该丝网支架经常规技术热处理以记忆其所示结构。在所示的示例中,适配器支架10基本为确定内腔的圆柱形丝结构。适配器支架10基本具有圆柱形近端部分12和远端部分14,各自直径足够大以接触其将被植入的流出道内部。该近端部分12和远端部分14朝向其中可安装带瓣静脉段或其它替换瓣膜的直径减小的基本圆柱形中部16逐渐缩小。Figure 1 shows an example of a prior art adapter stent 10 that has been developed to allow a valved bovine jugular segment to be used in a patient with a large right ventricular outflow tract. Stent 10 comprises a wire mesh scaffold made of Nitinol wire that has been heat treated by conventional techniques to memorize its configuration as shown. In the example shown, the adapter stent 10 is substantially a cylindrical wire structure defining a lumen. Adapter stent 10 generally has a cylindrical proximal portion 12 and a distal portion 14 each having a diameter large enough to contact the interior of the outflow tract into which it will be implanted. The proximal portion 12 and the distal portion 14 taper toward a substantially cylindrical central portion 16 of reduced diameter in which a valved vein segment or other replacement valve may be installed.

图2是图1所示适配器支架10的端视图,包括具有多个小叶20的带瓣静脉段18。静脉段18沿支架近端边缘和远端边缘缝合至适配器支架10,也可最大程度缝合于支架,如果并非覆盖静脉段的全部支架金属丝交叉处。附加缝合已说明为用于瓣膜结合处之间的区域。适当的瓣膜部件的组装的一个示例见受让人同时待决的以Philippe Bonhoeffer和Debra Ann Taitague等人名义于2005年11月18日提交并指定为美国第11/282,275号的美国专利申请《心脏瓣膜治疗设备及其制造方法》(Apparatus for Treatment of Cardiac Valvesand Method of Its Manufacture)。FIG. 2 is an end view of the adapter stent 10 shown in FIG. 1 including a valved vein segment 18 having a plurality of leaflets 20 . The vein segment 18 is sutured to the adapter stent 10 along the proximal and distal edges of the stent, and may also be sutured to the stent to the greatest extent, if not covering all of the stent wire intersections of the vein segment. Additional sutures have been described for the area between the valve commissures. An example of the assembly of suitable valve components is found in assignee's co-pending U.S. patent application, "Heart Apparatus for Treatment of Cardiac Valves and Method of Its Manufacture.

图3是图1所示类型的植入右心室流出道40的替换瓣膜的示意性横截面图。如图所示,适配器支架10的近端部分12和远端部分14的位置使得较大直径部分接触流出道40的内壁。适配器支架10可推开自体瓣膜小叶42,这允许带瓣静脉段18的小叶20植入自体瓣膜的原始位置。适配器支架10的位置也可使得近端段压缩自体小叶抵住流出道壁或也可定位于自体小叶42的下游。3 is a schematic cross-sectional view of a replacement valve of the type shown in FIG. 1 implanted in the right ventricular outflow tract 40 . As shown, the proximal portion 12 and the distal portion 14 of the adapter stent 10 are positioned such that the larger diameter portion contacts the inner wall of the outflow channel 40 . The adapter stent 10 can push away the native valve leaflets 42, which allows the leaflets 20 of the valved vein segment 18 to implant in the original position of the native valve. The location of the adapter stent 10 can also be such that the proximal segment compresses the native leaflet against the outflow tract wall or can also be positioned downstream of the native leaflet 42 .

但是,仍需要提供各种装置以适合不同病人,也需要改进移植直径相对较小的瓣膜段于直径相对较大的病人区域内可用的装置。However, there remains a need to provide a variety of devices to suit different patients, as well as to improve devices usable for implanting relatively smaller diameter valve segments in relatively larger diameter patient regions.

发明内容 Contents of the invention

本发明一般是要提供允许在替换瓣膜期望位置直径大于可用替换瓣膜直径的位置使用替换瓣膜的机构。更具体地,本发明是要提供允许带瓣静脉段(如牛颈静脉)用作具有较大右心室流出道的病人体内的替换肺动脉瓣膜的机构。但是,本发明也可与例如授权给Cox的美国专利No.6,719,789和No.5,480,424公开的其它替换瓣膜或例如包括心包组织、镍钛诺金属和/或聚合体的其它瓣膜结合使用。可进一步设想猪或马静脉段可与本发明的装置结合使用。The present invention generally seeks to provide a mechanism that permits the use of a replacement valve at a location where the desired location of the replacement valve has a larger diameter than the available replacement valve. More specifically, the present invention seeks to provide a mechanism that allows a valved venous segment, such as the bovine jugular vein, to be used as a replacement pulmonary valve in patients with a large right ventricular outflow tract. However, the present invention may also be used in conjunction with other replacement valves such as those disclosed in US Pat. Nos. 6,719,789 and 5,480,424 to Cox or other valves comprising, for example, pericardial tissue, nitinol metal, and/or polymers. It is further contemplated that segments of porcine or equine veins may be used in conjunction with the devices of the present invention.

本发明通过提供可扩张适配器支架实现上述目标,该可扩张适配器支架的结构为扩张时具有基本圆柱形外壁且该外壁直径大至足以接合并密封期望移植部位处的脉管内壁。适配器支架进一步包括内部,该内部基本为圆柱形且直径小于适配器支架外壁的直径。该内部的壁沿适配器支架长度延伸,且该内部的壁的内直径基本等于定位其中或将定位其中的带瓣静脉段或其它替换瓣膜的外直径。The present invention achieves the above objects by providing an expandable adapter stent configured to have a substantially cylindrical outer wall when expanded with a diameter large enough to engage and seal the inner vessel wall at the desired graft site. The adapter holder further includes an interior that is substantially cylindrical and has a diameter that is smaller than the diameter of the outer wall of the adapter holder. The inner wall extends along the length of the adapter stent and has an inner diameter substantially equal to the outer diameter of a valved vein segment or other replacement valve positioned or to be positioned therein.

在本发明的第一结构中,带瓣静脉段或其它替换瓣膜在移植前定位于适配器支架的内部。在第二结构中,带瓣静脉段或其它替换瓣膜在适配器支架先植入后置于适配器支架的内部中。在此实施例中,替换瓣膜可自身安装于可扩张瓣膜支架内,如以上所引用的Tower等人的应用和Bonhoeffer等人的论文中所述。本发明所使用的支架可为如由镍钛诺金属制成的自扩张支架类型或可为通过例如球囊等装置可扩张的支架。在下述优选实施例中,本发明的适配器支架提供为由具有内部空间以在延长期间封入液体或凝胶材料物质的液体不渗透外结构组成的管状结构。这样,所有血流将引导通过其中定位替换瓣膜的适配器支架的内部。In a first configuration of the invention, a valved vein segment or other replacement valve is positioned inside the adapter stent prior to implantation. In a second configuration, a valved vein segment or other replacement valve is placed within the interior of the adapter stent after the adapter stent is first implanted. In this embodiment, the replacement valve may itself fit within an expandable valve stent as described in the Tower et al. application and the Bonhoeffer et al. paper cited above. The stent used in the present invention may be a self-expanding stent type such as made of Nitinol metal or may be a stent expandable by a device such as a balloon. In the preferred embodiment described below, the adapter stent of the present invention is provided as a tubular structure consisting of a liquid-impermeable outer structure with an inner space to enclose a liquid or gel material substance during prolongation. In this way, all blood flow will be directed through the interior of the adapter holder in which the replacement valve is positioned.

在本发明的一方面中,提供了一种放置瓣膜于直径大于瓣膜直径的管状器官内的方法。该方法包括输送可扩张管状适配器至管状器官内的期望部位,其中适配器包括由具第一直径的圆柱形外壁环绕的封闭容积,圆柱形外壁与具有小于第一直径的第二直径的圆柱形内壁同心隔开,第一端壁和第二端壁分别延伸于圆柱形外壁和圆柱形内壁之间的适配器近端和远端处。该方法还包括相对圆柱形内壁扩张圆柱形外壁使得圆柱形外壁接触管状器官,并放置瓣膜于适配器的圆柱形内壁内。该方法还包括置入材料于适配器的封闭容积内以相对于内壁扩张外壁,其材料可包括例如液体或凝胶且可为完全或部分硬化的材料。可替换地,瓣膜可在适配器被输送至期望部位前定位于圆柱形内壁内。In one aspect of the invention, a method of placing a valve in a tubular organ having a diameter greater than the diameter of the valve is provided. The method includes delivering an expandable tubular adapter to a desired location within the tubular organ, wherein the adapter includes an enclosed volume surrounded by an outer cylindrical wall having a first diameter, the outer cylindrical wall and an inner cylindrical wall having a second diameter less than the first diameter Concentrically spaced, first and second end walls extend respectively at the proximal and distal ends of the adapter between the outer cylindrical wall and the inner cylindrical wall. The method also includes expanding the outer cylindrical wall relative to the inner cylindrical wall such that the outer cylindrical wall contacts the tubular organ, and placing the valve within the inner cylindrical wall of the adapter. The method also includes placing a material within the enclosed volume of the adapter to expand the outer wall relative to the inner wall, the material may include, for example, a liquid or gel and may be a fully or partially hardened material. Alternatively, the valve may be positioned within the cylindrical inner wall before the adapter is delivered to the desired site.

在本发明的另一方面中,提供了一种放置瓣膜于直径大于瓣膜直径的管状器官内的设备。该设备包括由具有第一直径的圆柱形外壁环绕的封闭容积,圆柱形外壁与具有小于第一直径的第二直径的圆柱形内壁同心隔开,且第一端壁和第二端壁分别延伸于圆柱形外壁和圆柱形内壁之间的适配器近端和远端处。所述设备还包括封闭容积内包含的一定量的材料和安装于适配器的圆柱形内壁内的瓣膜。外壁、内壁或外壁和内壁可包括伸出表面的至少一个凸起,以与至少一部分瓣膜配合。In another aspect of the invention, an apparatus for placing a valve in a tubular organ having a diameter greater than the diameter of the valve is provided. The device includes an enclosed volume surrounded by a cylindrical outer wall having a first diameter spaced concentrically from a cylindrical inner wall having a second diameter smaller than the first diameter, and a first end wall and a second end wall respectively extending at the proximal and distal ends of the adapter between the outer cylindrical wall and the inner cylindrical wall. The device also includes a quantity of material contained within the enclosed volume and a valve mounted within the cylindrical inner wall of the adapter. The outer wall, the inner wall, or both can include at least one protrusion protruding from the surface to engage at least a portion of the valve.

附图说明 Description of drawings

现将参照附图进一步说明本发明,其中贯穿几个附图的相同结构由相同数字表示,且其中:The present invention will now be further described with reference to the accompanying drawings, in which like structures are represented by like numerals throughout the several figures, and in which:

图1是示例性现有技术的适配器支架的侧视图;Figure 1 is a side view of an exemplary prior art adapter bracket;

图2是图1所示的适配器支架的示意性端视图,其中安装有带瓣静脉段;Figure 2 is a schematic end view of the adapter holder shown in Figure 1 with a valved vein segment installed therein;

图3是植入右心室流出道内的图1所示类型的替换瓣膜的横截面侧视图;Figure 3 is a cross-sectional side view of a replacement valve of the type shown in Figure 1 implanted in the right ventricular outflow tract;

图4是根据本发明的适配器支架的实施例的透视图;Figure 4 is a perspective view of an embodiment of an adapter bracket according to the present invention;

图5是图4所示的适配器支架的横截面侧视图;Figure 5 is a cross-sectional side view of the adapter bracket shown in Figure 4;

图6是如以上引用的Tower等人和Bonhoeffer等人的参考文献中所述的带支架带瓣静脉段的侧视图;Figure 6 is a side view of a stented valved vein segment as described in the Tower et al. and Bonhoeffer et al. references cited above;

图7是根据本发明输送带瓣静脉段的输送系统的侧视图;Figure 7 is a side view of a delivery system with a valve segment according to the present invention;

图8是由图7所示系统输送的图6所示的带瓣静脉段的侧视图;Figure 8 is a side view of the valved vein segment shown in Figure 6 delivered by the system shown in Figure 7;

图9是植入右心室流出道内的定位于本发明的适配器支架内的替换瓣膜的横截面侧视图;Figure 9 is a cross-sectional side view of a replacement valve positioned within an adapter stent of the present invention implanted in the right ventricular outflow tract;

图10是根据本发明的适配器支架的输送系统的侧视图;Figure 10 is a side view of a delivery system for an adapter stent according to the present invention;

图11是适配器支架另一实施例的局部横截面图,该适配器支架包括从适配器支架外表面向外伸出的梁或凸起;11 is a partial cross-sectional view of another embodiment of an adapter bracket including beams or protrusions extending outwardly from an outer surface of the adapter bracket;

图12是适配器支架另一实施例的局部横截面图,该适配器支架包括向内伸向适配器支架内开放通道的梁或凸起;Figure 12 is a partial cross-sectional view of another embodiment of an adapter bracket including beams or protrusions extending inwardly toward an open channel in the adapter bracket;

图13是根据本发明的适配器支架的另一实施例的横截面图,该适配器支架包括位于其中的瓣膜段;Figure 13 is a cross-sectional view of another embodiment of an adapter stent including a valve segment therein according to the present invention;

图14是根据本发明另一实施例的连接到支架的瓣膜的示意性透视图;Figure 14 is a schematic perspective view of a valve attached to a stent according to another embodiment of the present invention;

图15是本发明适配器支架的另一实施例的横截面侧视图,该适配器支架包括处于第一位置的图14所示的瓣膜和支架;以及15 is a cross-sectional side view of another embodiment of an adapter stent of the present invention comprising the valve and stent shown in FIG. 14 in a first position; and

图16是图15所示适配器支架的横截面侧视图,该适配器支架包括处于第二位置的图14所示的瓣膜和支架。16 is a cross-sectional side view of the adapter stent shown in FIG. 15 including the valve and stent shown in FIG. 14 in a second position.

具体实施方式 Detailed ways

现参照附图,其中相同部件以相同数字标注,且首先参照图4和5,示出了根据本发明的适配器支架200的示例性结构。适配器支架200可用于将漏斗状器官或右心室流出道减小为适合经皮肺动脉瓣膜的直径。即,适配器支架200提供了尺寸或直径适当的区域以接受瓣膜置入,如在漏斗状器官或右心室流出道过大从而不适于该瓣膜的区域内。适配器支架200包括基本圆柱形球囊202,该基本圆柱形球囊202环绕基本延伸经过其中心的内通道204。由球囊202的内壁206确定的该内通道204相对于球囊202的外表面208而基本同心定位,尽管可能至少稍有偏移。端壁210和212延伸于内壁206和外表面208之间,从而为球囊202提供封闭的管状结构。端壁210和212可基本笔直或平坦并沿基本垂直方向从内壁206和外表面208中的一者或两者朝向内壁206和208中的另一者延伸。可替换地,端壁210和212也可为提供内壁206和外表面208之间的平滑过渡表面的球囊的基本凹入或凸起部分。Referring now to the drawings, in which like parts are numbered the same, and initially to FIGS. 4 and 5, there is shown an exemplary construction of an adapter bracket 200 in accordance with the present invention. Adapter stent 200 may be used to reduce the infundibulum or right ventricular outflow tract to a diameter suitable for a percutaneous pulmonary valve. That is, the adapter stent 200 provides an area of the appropriate size or diameter to accept valve placement, such as in areas where the infundibulum or right ventricular outflow tract is too large to accommodate the valve. Adapter stent 200 includes a substantially cylindrical balloon 202 surrounding an inner channel 204 extending substantially through its center. The inner channel 204 defined by the inner wall 206 of the balloon 202 is positioned substantially concentrically with respect to the outer surface 208 of the balloon 202, although possibly at least slightly offset. End walls 210 and 212 extend between inner wall 206 and outer surface 208 to provide balloon 202 with a closed tubular structure. End walls 210 and 212 may be substantially straight or flat and extend in a substantially vertical direction from one or both of inner wall 206 and outer surface 208 toward the other of inner walls 206 and 208 . Alternatively, end walls 210 and 212 may also be substantially concave or convex portions of the balloon that provide a smooth transition surface between inner wall 206 and outer surface 208 .

如下进一步的描述,球囊202可以基本紧缩或折叠状态置入病人体内,之后顺序填充多种物质之一或更多。例如,这些物质可为不硬化类型,如空气或粘度不同的液体。在此情况下,球囊可被提供有保持球囊内包含的材料(即避免泄漏)的机构,如塞子或其它闭合机构。也可设想球囊自身由自密封类型材料构造,该自密封类型材料可穿孔或另行破损以允许通过喷嘴或其它装置填充球囊,并且该自密封类型材料在球囊填充装置被去除后将自行再次密封。可替换地,球囊可填充化合物,该化合物可完全或部分硬化从而使该化合物一旦被硬化则不能从球囊泄漏或转移。该可硬化材料可在其注入或置入球囊内后在其中快速或即时硬化,或该材料可在一段时间内逐渐硬化,如响应周围体液和组织的温度。可用于球囊内的其它示例性材料包括以下各项:盐水、胶原质、硅酮、水凝胶、血液、泡沫、由玻璃制成的小珠或小球、聚合体或金属等。As described further below, balloon 202 may be placed into a patient in a substantially deflated or collapsed state and thereafter sequentially filled with one or more of a variety of substances. For example, these substances may be of a non-hardening type such as air or liquids of different viscosities. In this case, the balloon may be provided with a mechanism, such as a plug or other closure mechanism, to retain the material contained within the balloon (ie avoid leakage). It is also conceivable that the balloon itself is constructed of a self-sealing type of material that can be perforated or otherwise broken to allow filling of the balloon through a nozzle or other device, and which will self-contain after the balloon filling device is removed. Seal again. Alternatively, the balloon may be filled with a compound that may be fully or partially hardened such that the compound cannot leak or transfer from the balloon once hardened. The hardenable material may harden rapidly or instantaneously therein after it is injected or placed within the balloon, or the material may gradually harden over a period of time, such as in response to the temperature of surrounding body fluids and tissues. Other exemplary materials that may be used within the balloon include the following: saline, collagen, silicone, hydrogel, blood, foam, beads or spheres made of glass, polymers or metals, and the like.

尽管以上说明球囊和/或适配器支架为基本圆柱形形状,则可以理解球囊也可以本发明范围内的多种方式成形。例如,球囊可具有例如基本为椭圆形、卵形、球形或不规则形状的外壁,且该球囊的内壁的形状可与外壁的形状相同或不同。在任一情况下,内壁被构造为容纳瓣膜,且外壁被构在为可使其面积的充分大的部分稳固接触其置入的身体开口。即,球囊的外壁可具有例如适合右心室流出道的先天不规则所必需的多种不规则形状的轮廓。在此方面,球囊和/或适配器支架可具有处于折叠或半折叠状态时基本为圆柱形的外壁,但该球囊和/或适配器支架相对一致从而使其外壁在适当身体开口内扩张时相对不规则。因此,本发明的适配器支架可用于体内不包括规则形状管状开口的区域。另外,对于任何球囊和/或适配器支架,内通道相对球囊的外表面可稍有偏移或严重偏移(即不同心)。While the balloon and/or adapter holder have been described above as being substantially cylindrical in shape, it will be appreciated that the balloon may also be shaped in a variety of ways within the scope of the present invention. For example, a balloon may have an outer wall, eg, substantially oval, oval, spherical, or irregularly shaped, and the inner wall of the balloon may be the same or different in shape than the outer wall. In either case, the inner wall is configured to receive the valve and the outer wall is configured to securely contact a body opening into which it is inserted for a sufficiently large portion of its area. That is, the outer wall of the balloon may have various irregularly shaped contours, eg, necessary to accommodate congenital irregularities of the right ventricular outflow tract. In this regard, the balloon and/or adapter stent may have an outer wall that is substantially cylindrical when in a folded or semi-folded state, but which is relatively conformal such that its outer wall is opposite when expanded within a suitable body opening. irregular. Accordingly, the adapter stent of the present invention can be used in areas of the body that do not include regularly shaped tubular openings. Additionally, as with any balloon and/or adapter scaffold, the inner channel may be slightly or significantly offset (ie, not concentric) relative to the outer surface of the balloon.

球囊202可由与其内含材料相容且优选为体液不可渗透的任何材料制成。在本发明的任一实施例中,球囊可由一种或多种材料形成,该材料形成可在延长期间内保持球囊扩张状态的连续管道。即,一旦球囊已密封,则球囊内部区域内放置的材料应不能转移或泄漏,且球囊外的流体应不能移入球囊的内部区域。换句话说,制成球囊的材料应不能渗透其接触的任何流体。示例性球囊材料包括PTFE(聚四氟乙烯)或ePTFE(膨体聚四氟乙烯),但也可使用大范围的不可渗透材料或材料组合。还可设想球囊表面可包括有助于组织内生或血管翳的材料,如具有生物相容和生物稳定涂层的织物或其它材料和/或有助于置入位置中的球囊修复的表面结构。这种材料可构成整个球囊,或仅部分球囊可包括有助于组织内生的材料。Balloon 202 may be made of any material that is compatible with its contents and is preferably impermeable to body fluids. In any of the embodiments of the invention, the balloon may be formed from one or more materials that form a continuous conduit that maintains the balloon's expanded state for an extended period of time. That is, once the balloon has been sealed, materials placed within the interior region of the balloon should not transfer or leak, and fluid outside the balloon should not migrate into the interior region of the balloon. In other words, the material from which the balloon is made should be impermeable to any fluids it contacts. Exemplary balloon materials include PTFE (polytetrafluoroethylene) or ePTFE (expanded polytetrafluoroethylene), although a wide range of impermeable materials or combinations of materials may also be used. It is also contemplated that the balloon surface may include materials that facilitate tissue ingrowth or pannus, such as fabrics or other materials with biocompatible and biostable coatings and/or that facilitate balloon repair in place. surface structure. This material may make up the entire balloon, or only a portion of the balloon may include material that facilitates tissue ingrowth.

在本发明的一个结构中,构成球囊202的材料足够柔软以适合多种组织从而使一特定尺寸和形状的适配器支架200可被构造为用于多种病人体内。另外,球囊202期望被设计为提供膨胀时不论内壁206和外表面208相隔距离多远均具有预定尺寸的内通道204。即,如果球囊202将扩张以适合异常大的组织,则内通道204可保持预定直径以接受瓣膜处于其适当方位。因此,球囊202可由单个材料构成或由在球囊特定区域内的厚度或其它属性中变化以允许获得期望扩张轮廓的材料、部分和/或部件的组合构成。例如,与组成外表面208的球囊部分相比,组成内壁206的球囊202部分可相对不可变形或不可扩张,使得添加材料至球囊202的内部区域将不允许球囊202扩张至内通道204内,而仅允许球囊202的外表面208扩张至远离内壁206。这样,内通道204的直径可保持为接受替换瓣膜的特定尺寸。另外,端壁210和端壁212之间的距离优选为在球囊202折叠或球囊202部分或完全扩张时近似相等。但是,球囊202的长度也可在材料置入其中时至少稍稍增大。In one configuration of the invention, the material making up balloon 202 is sufficiently flexible to conform to a variety of tissues so that a particular size and shape of adapter holder 200 can be configured for use in a variety of patients. Additionally, the balloon 202 is desirably designed to provide the inner passage 204 with a predetermined size when inflated regardless of the distance between the inner wall 206 and the outer surface 208 . That is, if balloon 202 is to expand to fit abnormally large tissue, inner channel 204 may maintain a predetermined diameter to accept the valve in its proper orientation. Accordingly, balloon 202 may be constructed of a single material or of combinations of materials, portions, and/or components that vary in thickness or other properties within specific regions of the balloon to allow for a desired expansion profile. For example, the portion of balloon 202 that makes up inner wall 206 may be relatively non-deformable or non-expandable compared to the portion of balloon that makes up outer surface 208, such that adding material to the interior region of balloon 202 will not allow balloon 202 to expand into the inner passageway. 204 while only allowing the outer surface 208 of the balloon 202 to expand away from the inner wall 206 . In this way, the diameter of the inner channel 204 can be maintained to accept the specific size of the replacement valve. Additionally, the distance between end wall 210 and end wall 212 is preferably approximately equal when balloon 202 is collapsed or when balloon 202 is partially or fully expanded. However, the length of balloon 202 may also increase at least slightly as material is placed therein.

本发明的球囊的扩张可包括制成球囊的材料响应于添加材料至球囊内部容积的实际拉伸或扩张。但在其它实施例中,材料自身实际不扩张或拉伸,而球囊内部容积的填充使得球囊壁相互远离,从而扩大内部球囊容积。Expansion of the balloon of the present invention may involve actual stretching or expansion of the material from which the balloon is made in response to adding material to the internal volume of the balloon. In other embodiments, however, the material itself does not actually expand or stretch, and filling of the interior volume of the balloon causes the walls of the balloon to move away from each other, thereby expanding the interior balloon volume.

球囊202可由一种或多种物质覆盖或部分覆盖以控制或避免瓣膜内生并密封,如涤纶、PTFE、组织等。制成球囊的材料可包括初次使用时基本无空隙但允许植入前短期有限泄漏的材料。这种类型的材料在植入时变得不可渗透。金属支架材料也可与球囊材料结合使用以允许球囊202的特制径向力。另外,球囊可包括例如环、倒刺、钩、齿或伸出或伸入内壁球囊材料、外壁球囊材料或内壁和外壁球囊材料内的其它凸起或凹陷。该结构的一个示例见图11中所示的适配器支架250。适配器支架250包括基本圆柱形球囊252,该基本圆柱形球囊252环绕基本延伸穿过该基本圆柱形球囊252中心的内通道254。球囊252包括定义了内通道254的内壁256,其中内通道254具有在其长度上基本恒定的直径。球囊252还包括与内壁256隔开的外壁258。至少一个凸起260从外壁258向外延伸,该凸起260可用作例如分立凸块或球块,或可包括绕球囊252全部外边界或部分外边界延伸的梁。凸起260可相互隔开,如图所示,或可为外壁258的连续构造表面。凸起260的另一可替换的结构包括沿球囊252的长度连续或半连续延伸的一个或多个旋梁。Balloon 202 may be covered or partially covered with one or more substances to control or prevent valve ingrowth and seal, such as Dacron, PTFE, tissue, and the like. The material from which the balloon is made can include a material that is substantially void-free on first use but allows limited leakage short-term prior to implantation. This type of material becomes impermeable when implanted. Metal scaffold materials may also be used in combination with balloon materials to allow for tailored radial forces of the balloon 202 . Additionally, the balloon may include, for example, loops, barbs, hooks, teeth, or other protrusions or indentations that protrude or protrude into the inner balloon material, the outer balloon material, or both. An example of this structure is shown in adapter bracket 250 shown in FIG. 11 . Adapter stent 250 includes a substantially cylindrical balloon 252 surrounding an inner channel 254 extending substantially through the center of substantially cylindrical balloon 252 . Balloon 252 includes an inner wall 256 that defines an inner channel 254, wherein inner channel 254 has a substantially constant diameter over its length. Balloon 252 also includes an outer wall 258 spaced from inner wall 256 . Extending outwardly from outer wall 258 is at least one protrusion 260 which may serve as, for example, a discrete bump or bump, or may comprise a beam extending around all or a portion of the outer perimeter of balloon 252 . The protrusions 260 may be spaced apart from each other, as shown, or may be a continuous textured surface of the outer wall 258 . Another alternative configuration for protrusion 260 includes one or more swing beams extending continuously or semi-continuously along the length of balloon 252 .

选择从外壁258伸出的任何凸起260的数量、间隔和特定结构以提供和/或促进适配器支架相对于特定程序的特定部件。即,可提供这些凸起以例如增加球囊252的径向力、减少其转移的风险和/或增进适配器支架的整个结构完整性。提供的任何凸起260可使用与制成球囊的材料相同或不同的材料与外壁258整体成形或可粘于或另行连于球囊252。这种可替换的凸起的一个示例是伸入外壁258并从外壁258伸出的塞子,例如明尼苏达州(Minnesota)金山谷市(Golden Valley)的AGA医药公司商购类型的名为“安普拉兹(AMPLATZER)血管塞”的自扩张圆柱形网丝装置。The number, spacing and specific configuration of any protrusions 260 extending from the outer wall 258 are selected to provide and/or facilitate specific features of the adapter holder with respect to specific procedures. That is, these protrusions may be provided, for example, to increase the radial force of balloon 252, reduce the risk of its migration, and/or enhance the overall structural integrity of the adapter stent. Any protrusions 260 provided may be integrally formed with the outer wall 258 or may be adhered or otherwise attached to the balloon 252 using the same or a different material from which the balloon is made. An example of such an alternative protrusion is a plug that extends into and out of the outer wall 258, such as the type commercially available from AGA Pharmaceuticals, Golden Valley, Minnesota, under the name "Amp". Lazi (AMPLATZER) vascular plug "self-expanding cylindrical mesh device.

图12示出了适配器支架270的另一实施例的一部分,包括球囊272,该球囊272环绕延伸基本穿过球囊272中心的内通道274。球囊272包括与确定内通道274的内壁278隔开的外壁276。外壁276具有在其长度上基本恒定的直径;但内壁278包括伸入内通道274的至少一个凸起280。凸起280可根据需要包括以上相对于从适配器支架250外壁258伸出的凸起所述或设想的任何变化。该凸起280的一个功能是控制适配器支架内新瓣膜的位置,例如以避免瓣膜转移。即,该凸起有助于引入、定位和/或固定瓣膜于适配器支架内。另外,单个适配器支架可使用从其内壁和外壁伸出且沿所有或部分壁长的凸起组合。FIG. 12 shows a portion of another embodiment of an adapter stent 270 including a balloon 272 surrounding an inner channel 274 extending substantially through the center of the balloon 272 . Balloon 272 includes an outer wall 276 spaced from an inner wall 278 defining an inner passage 274 . The outer wall 276 has a substantially constant diameter throughout its length; however, the inner wall 278 includes at least one protrusion 280 that projects into the inner passage 274 . The protrusion 280 may comprise any variation described or contemplated above with respect to the protrusion extending from the outer wall 258 of the adapter bracket 250, as desired. One function of this protrusion 280 is to control the position of the new valve within the adapter stent, eg to avoid valve migration. That is, the protrusions aid in introducing, positioning and/or securing the valve within the adapter holder. Alternatively, a single adapter bracket may use a combination of protrusions protruding from its inner and outer walls and along all or part of the wall length.

图13示出了适配器支架300的又一实施例,还包括定位于其中的瓣膜段302。适配器支架300包括环绕基本圆柱形内通道306的球囊304。内通道306包括至少一个曲线部分308,从而改变沿其部分长度上的内通道306的直径。在一个实施例中,提供了分立的曲线部分308以相应于将用于其中的特定瓣膜的各小叶。即,如果将使用三叶瓣膜,则可提供三个相应的曲线或球形部分308。因此,曲线部分308可相应于将置入瓣膜的解剖或天然形状。但是,曲线部分308也可绕球囊304全部或部分内边界连续。这种曲线部分可替换或额外地提供于适配器支架外壁上以符合病人的组织。Figure 13 illustrates yet another embodiment of an adapter stent 300, further including a valve segment 302 positioned therein. Adapter stent 300 includes a balloon 304 surrounding a substantially cylindrical inner channel 306 . Inner channel 306 includes at least one curved portion 308, thereby varying the diameter of inner channel 306 along a portion of its length. In one embodiment, discrete curved portions 308 are provided to correspond to the leaflets of the particular valve to be used therein. That is, if a tri-leaflet valve is to be used, three corresponding curved or spherical portions 308 may be provided. Accordingly, curved portion 308 may correspond to the anatomical or natural shape of the valve to be implanted. However, curved portion 308 may also be continuous around all or part of the inner boundary of balloon 304 . Such curved portions may alternatively or additionally be provided on the outer wall of the adapter holder to conform to the patient's anatomy.

图6示出了已开发的带支架瓣膜静脉段50的另一示例,该带支架瓣膜静脉段50可定位于先植入如适配器支架200的适配器支架内。带支架静脉段50可相应于上述所引用的Tower等人和Bonhoeffer等人的参考文献所述,并基本包括支架52和静脉段54。带支架静脉段50的外直径可扩张至与适配器支架202的内通道204的直径一样大。支架52可由铂、不锈钢或其它生物相容金属制成。尽管可如以上所引Tower等人的申请中所述使用丝材制造,但也可通过加工金属管为支架而制造。静脉段54安装于支架52内,该静脉段54包括的瓣膜位于支架两端之间并通过缝合处56固定于支架。缝合处56位于支架的近端和远端处,且优选位于支架的所有或几乎所有交叉处,如图所示。制造带支架静脉段的更详细说明见受让人同时待决的以Philippe Bonhoeffer和Debra Ann Taitague等人名义于2005年11月18日提交并指定为美国No.11/282,275的美国专利申请《心脏瓣膜治疗设备及其制造方法》。FIG. 6 shows another example of a stented valve vein segment 50 that has been developed that may be positioned within an adapter stent such as adapter stent 200 that was previously implanted. The stented vein segment 50 may correspond to that described in the above-cited Tower et al. and Bonhoeffer et al. references and essentially includes a stent 52 and a vein segment 54 . The outer diameter of the stented vein segment 50 is expandable to be as large as the diameter of the inner channel 204 of the adapter stent 202 . Stent 52 may be made of platinum, stainless steel, or other biocompatible metal. Although fabricated using wire as described in the above-cited Tower et al. application, it can also be fabricated by machining metal tubes into stents. The vein segment 54 is installed in the bracket 52 , and the valve included in the vein segment 54 is located between two ends of the bracket and fixed to the bracket by a suture 56 . Stitches 56 are located at the proximal and distal ends of the stent, and preferably at all or nearly all intersections of the stent, as shown. A more detailed description of the fabrication of stented vein segments is found in assignee's co-pending U.S. Patent Application, "Heart Valve Therapy Devices and Methods of Making the Same.

图7示出了输送图6所示类型的带瓣膜静脉段至先植入如适配器支架200的适配器支架内部的系统。输送系统60包括覆盖内球囊导管(图中不可见)的外壳62。外壳包括扩张的远端部分64,带支架带瓣膜静脉段置于该扩张的远端部分64中。静脉段压缩于内导管上的单个或双球囊周围。减缩尖端66安装于内导管的远端以有助于输送系统通过病人的脉管系统。所述系统也包括导丝68,可用于引导输送系统至其所需的植入位置。FIG. 7 shows a system for delivering a valved vein segment of the type shown in FIG. Delivery system 60 includes a housing 62 covering an inner balloon catheter (not visible in the figure). The housing includes an expanded distal portion 64 into which the stented valved vein segment is positioned. The venous segment is compressed around a single or double balloon on the inner catheter. A tapering tip 66 is mounted on the distal end of the inner catheter to facilitate passage of the delivery system through the patient's vasculature. The system also includes a guide wire 68 that can be used to guide the delivery system to its desired implantation site.

图7的输送系统及其使用可与以上所引Tower等人申请所述相同,除了静脉段置于预先放置在例如适配器支架200的适配器支架中部内,而不是扩张抵住失常的自体或人工瓣膜。输送系统可使用导丝68前移至期望的瓣膜植入部位,之后收回外壳62以允许静脉段的球囊扩张,如图8所示,如下所述。The delivery system of FIG. 7 and its use may be the same as described in the above-cited Tower et al. application, except that the vein segment is placed within the middle of an adapter stent pre-placed, such as adapter stent 200, rather than expanded against a malfunctioning native or prosthetic valve. . The delivery system can be advanced using guidewire 68 to the desired valve implantation site, after which housing 62 is retracted to allow balloon inflation of the venous segment, as shown in Figure 8, as described below.

图8示出了在如适配器支架200的预先植入适配器支架中部内的如静脉段50的膨胀带支架带瓣膜静脉段的机构。外壳62移向近端,露出安装于内导管70上的球囊72。球囊72扩张,从而扩张静脉段50抵住预先植入的适配器支架的内表面,稳定并密封静脉段于适配器支架内。如果适配器支架内提供有凸起或其它引入部件,则静脉段50可与该部件接合。之后球囊紧缩并向近端退回输送系统。FIG. 8 shows the mechanism of expanding a stented valved vein segment such as vein segment 50 within the middle of a pre-implanted adapter stent such as adapter stent 200 . Housing 62 moves proximally, exposing balloon 72 mounted on inner catheter 70 . The balloon 72 expands, thereby expanding the vein segment 50 against the inner surface of the pre-implanted adapter stent, stabilizing and sealing the vein segment within the adapter stent. If a protrusion or other lead-in feature is provided within the adapter holder, the vein segment 50 can engage with that feature. The balloon is then deflated and the delivery system is retracted proximally.

图9是在本发明的适配器支架200内植入右心室流出道40的替换瓣膜的示意性横截面视图。如上所述,该替换瓣膜可在适配器支架植入病人的同时植入适配器支架200内,或替换瓣膜也可在植入适配器支架200后的一段时间植入。如图所示,适配器支架200的外表面208扩张抵住流出道40的内壁。如上面提出的,内通道204优选为保持适于固定并保持替换瓣膜的特定直径。因此,根据流出道40的尺寸,外表面208可相对靠近内通道204或与内通道204隔开较远。换句话说,如果流出道较大,则与流出道不大的结构相比,外表面208将与内通道204相隔较远。Figure 9 is a schematic cross-sectional view of a replacement valve implanted in the right ventricular outflow tract 40 within the adapter stent 200 of the present invention. As noted above, the replacement valve may be implanted in adapter stent 200 at the same time the adapter stent is implanted in the patient, or the replacement valve may be implanted some time after adapter stent 200 is implanted. As shown, the outer surface 208 of the adapter bracket 200 expands against the inner wall of the outflow channel 40 . As noted above, the inner channel 204 is preferably maintained at a specific diameter suitable for securing and maintaining the replacement valve. Thus, depending on the size of the spout 40 , the outer surface 208 may be relatively close to the inner channel 204 or spaced farther from the inner channel 204 . In other words, if the outflow is larger, the outer surface 208 will be spaced farther from the inner channel 204 than if the outflow is not large.

适配器支架200的外表面208优选在其整个长度上接触流出道40的内表面,但部分外表面208也可不接触流出道。在任意情况下,充足的外表面208应与流出道40接触以完成密封并避免其在植入后的转移。附图所示适配器支架安装于自体瓣膜小叶42的下游以允许其在适配器支架200和带支架静脉段50植入期间持续工作。非必须地,静脉段50可在其最初植入后几周内被置于适配器支架200内。在此附图中,所示静脉段54的小叶58也位于适配器支架200内。The outer surface 208 of the adapter bracket 200 preferably contacts the inner surface of the spout 40 throughout its entire length, although portions of the outer surface 208 may not contact the spout. In any event, sufficient outer surface 208 should be in contact with outflow tract 40 to complete the seal and prevent its migration after implantation. The adapter stent is shown mounted downstream of the native valve leaflets 42 to allow continued operation during the implantation of the adapter stent 200 and stented vein segment 50 . Optionally, vein segment 50 may be placed within adapter stent 200 within a few weeks of its initial implantation. In this figure, the leaflets 58 of the vein segment 54 are also shown within the adapter holder 200 .

图10示出了可用于输送根据本发明的适配器支架的一个示例性系统,该系统与用于输送静脉段的系统稍稍相似。输送系统21包括覆盖内导管(附图中不可见)的外壳22。外壳22具有扩张的远端部分24,适配器支架200(具有或不具有带瓣膜静脉段)可置于其中。适配器支架200可最初处于折叠状态,压缩于内导管周围并由外壳22保持于其压缩结构。减缩尖端26安装于内导管的远端并用于有助于输送系统20通过脉管系统。所述系统也包括导丝28,导丝28可用于引导输送系统20至其期望的植入位置。Figure 10 illustrates an exemplary system that may be used to deliver an adapter stent according to the present invention, somewhat similar to the system used to deliver venous segments. The delivery system 21 comprises a housing 22 covering an inner catheter (not visible in the figures). Housing 22 has an expanded distal portion 24 into which adapter stent 200 (with or without a valved vein segment) may be placed. Adapter stent 200 may initially be in a collapsed state, compressed around the inner catheter and held in its compressed configuration by housing 22 . Reduction tip 26 is mounted on the distal end of the inner catheter and is used to facilitate passage of delivery system 20 through the vasculature. The system also includes a guide wire 28 that can be used to guide the delivery system 20 to its desired implantation site.

输送系统21还包括与适配器支架相通以在期望的植入部位膨胀或扩张的机构32。机构32可包括可提供期望材料至适配器支架200内部的多种装置,如可移动流体或凝胶至适配器支架200内的泵、可控制从而以预定量膨胀适配器支架200的压缩空气或其它气体源等。即,用于适配器支架200内的材料将确定用于膨胀或扩张的机构32的类型。非必须地,输送系统21和/或适配器支架200可提供有密封机构(未示出)以在材料注入或置入其中后密封或闭合适配器支架200内的任何开口以保持材料不从支架200泄漏。The delivery system 21 also includes a mechanism 32 in communication with the adapter stent to expand or expand at the desired implantation site. Mechanism 32 can include various devices that can provide desired materials to the interior of adapter holder 200, such as a pump that can move a fluid or gel into adapter holder 200, a source of compressed air or other gas that can be controlled to expand adapter holder 200 by a predetermined amount. wait. That is, the material used within adapter stent 200 will determine the type of mechanism 32 used to expand or expand. Optionally, delivery system 21 and/or adapter stent 200 may be provided with a sealing mechanism (not shown) to seal or close any openings in adapter stent 200 after material is injected or placed therein to keep material from leaking from stent 200 .

外壳22可响应于适配器支架200的扩张通过机构32移向近端,或通过从一端拉动外壳22而移向近端,从而允许适配器支架200远离内导管30扩张,如该装置结构所示。适配器支架200的远端段可接合心血管壁于期望的植入位置,从而稳定支架。之后外壳22进一步移向近端,释放适配器支架的近端段,其后适配器支架在其直径方向上自由扩张直至接触心血管壁。材料可持续添加至适配器支架200直至其膨胀或扩张至期望的尺寸。之后向近端收回输送系统。在特定结构中,带瓣膜静脉段预安装于适配器支架200内,使得其中安装有带瓣膜静脉段的适配器支架200的膨胀或扩张完成替换瓣膜的植入。可替换地,带瓣膜静脉段可在以后置入适配器支架内。Housing 22 can be moved proximally by mechanism 32 in response to expansion of adapter stent 200, or by pulling housing 22 from one end, thereby allowing adapter stent 200 to expand away from inner catheter 30, as shown in the device configuration. The distal segment of the adapter stent 200 can engage the vessel wall at the desired implantation location, thereby stabilizing the stent. Housing 22 is then moved further proximally, releasing the proximal segment of the adapter stent, after which the adapter stent is free to expand in its diameter until it contacts the vessel wall. Material can continue to be added to the adapter stent 200 until it expands or expands to the desired size. The delivery system is then retracted proximally. In certain configurations, the valved vein segment is pre-installed within the adapter stent 200 such that inflation or expansion of the adapter stent 200 with the valved vein segment installed therein completes the implantation of the replacement valve. Alternatively, the valved vein segment can be placed into the adapter holder at a later time.

已说明并示出的用于本发明的适配器支架的带支架带瓣膜静脉段可压缩以安装于病人体内且可例如通过输送系统的球囊部分扩张。但是,也应理解也可使用其它类型的带支架瓣膜,如称为自扩张的类型。该自扩张支架可压缩以安装至病人体内,之后容易地通过移除用于保持支架处于压缩状态的特定外力而扩张至期望尺寸。也可使用可以本文所述以外方式压缩并扩张的其它类型带支架瓣膜,只要瓣膜可置入于病人体内的适配器支架内。The stented valved vein segment described and shown for the adapter stent of the present invention is compressible for installation in a patient and expandable, for example, by the balloon portion of the delivery system. However, it should also be understood that other types of stented valves may also be used, such as the type known as self-expanding. The self-expanding stent is compressible to fit within a patient, and then easily expanded to a desired size by removing the specific external force used to maintain the stent in a compressed state. Other types of stented valves that can be compressed and expanded in ways other than those described herein can also be used, as long as the valve can be placed within an adapter stent in a patient.

再次参照图13,瓣膜段302已预连接或预安装于球囊304的内通道306中,使得植入程序可在单个步骤中完成。即,并非先安装适配器支架,之后再安装瓣膜段于内通道中,图13示出了适配器支架组件,该适配器支架组件允许外科医生免除使用具有球囊以扩张瓣膜段的输送系统。所示瓣膜段302基本为牛颈静脉形式,该牛颈静脉形式包括可扩张至球囊304的曲线部分308内的球形区域310。因球形区域310没有压缩或变形到球囊304的内通道306内,因此该结构可在小叶312上提供更小的应力,但允许基本保持其自体解剖形式。Referring again to FIG. 13 , the valve segment 302 has been preattached or preinstalled in the inner channel 306 of the balloon 304 so that the implantation procedure can be accomplished in a single step. That is, rather than installing the adapter stent first and then installing the valve segment in the inner channel, Figure 13 shows an adapter stent assembly that allows the surgeon to dispense with the use of a delivery system with a balloon to expand the valve segment. The illustrated valve segment 302 is substantially in the form of a bovine jugular vein including a spherical region 310 expandable into the curved portion 308 of the balloon 304 . This configuration may provide less stress on the leaflets 312 as the spherical region 310 is not compressed or deformed into the inner channel 306 of the balloon 304, but allows for its autoatomic form to be substantially maintained.

图14示出了连于根据本发明另一实施例的支架322内的瓣膜320(为清晰以虚线示出)的实施例,其中瓣膜320包括小叶324,且支架包括近端328和相对的远端326。近端328可在如通过缝合操作固定支架322至瓣膜320的程序期间至少部分覆盖例如组织。支架322可包括编织或丝网材料,或任何其它适当的支架材料。图15示出了位于适配器支架或球囊330内的图14所示的瓣膜-支架组件,其中小叶324基本位于球囊330的内通道332内,且支架322的近端328伸出球囊330的一端。支架322连接到球囊330,如通过绕支架322至少部分圆周缝合支架322的近端328至球囊330而连接支架322到球囊330。球囊330可提供有套囊或其它延伸部分(未示出)以连接支架而不影响球囊的强度。这时,其中安装有带支架瓣膜的适配器支架可装运至例如诊所。14 shows an embodiment of a valve 320 (shown in phantom for clarity) attached to a stent 322 according to another embodiment of the invention, wherein the valve 320 includes leaflets 324, and the stent includes a proximal end 328 and an opposite distal end. End 326. The proximal end 328 may at least partially cover, for example, tissue during a procedure of securing the stent 322 to the valve 320, such as by a suturing operation. Stent 322 may comprise a braided or wire mesh material, or any other suitable stent material. 15 shows the valve-stent assembly shown in FIG. 14 positioned within an adapter stent or balloon 330 with the leaflet 324 substantially within the inner channel 332 of the balloon 330 and with the proximal end 328 of the stent 322 protruding from the balloon 330. one end. Stent 322 is attached to balloon 330 , such as by suturing proximal end 328 of stent 322 to balloon 330 around at least a portion of the circumference of stent 322 to balloon 330 . Balloon 330 may be provided with a cuff or other extension (not shown) to attach the stent without compromising the strength of the balloon. At this point, the adapter stent with the stented valve installed therein can be shipped, for example, to a clinic.

非必须地,图14所示的瓣膜-支架组件可通过拉动支架322的远端326穿过球囊330的内通道332直至与图15相比基本内侧外翻而倒置为图16所示结构。这样,因压缩程序期间该区域内的材料容积小于带支架瓣膜将保持于内通道332内的材料容积,故连有带支架瓣膜的球囊可压缩为较小尺寸以使系统输送至病人体内。之后,适配器支架可以与相对本发明其它实施例所述的相同方式使用,如包括使用材料扩张球囊,移除输送装置等,但也可包括通过将支架322的远端326压回内通道332内以使其可以用作病人的瓣膜而颠倒上述置入处理的步骤。Optionally, the valve-stent assembly shown in FIG. 14 can be inverted into the configuration shown in FIG. 16 by pulling the distal end 326 of the stent 322 through the inner channel 332 of the balloon 330 until substantially everted as compared to FIG. 15 . Thus, since the volume of material in this region during the compression procedure is less than the volume of material that the stented valve will hold within inner channel 332, the balloon with the stented valve attached can be compressed to a smaller size for delivery of the system into the patient. Thereafter, the adapter stent can be used in the same manner as described with respect to other embodiments of the invention, such as including expanding the balloon with material, removing the delivery device, etc., but also by pressing the distal end 326 of the stent 322 back into the inner channel 332. The steps of the insertion process described above are reversed so that it can be used as a valve for the patient.

最后,尽管上述发明特别适用于替换右心室流出道内的瓣膜,但本发明可用于替换其它血管或其它管状器官内的瓣膜。同样,尽管公开了牛颈静脉作为用于实施本发明的带瓣段源,但其它来源动物或来源血管也可替代。同样,也可使用聚合体或薄金属瓣膜。另外,也可使用上述授权给Cox的美国专利No.6,719,789和No.5,480,424的所述类型的可替换的示例性替换瓣膜。同样,上述说明应视为示例性的,而不是限制性的。Finally, while the invention described above is particularly applicable to replacing valves in the right ventricular outflow tract, the invention may be used to replace valves in other blood vessels or other tubular organs. Also, while bovine jugular vein is disclosed as a source of valved segments for use in the practice of the present invention, other sources of animals or sources of blood vessels may be substituted. Likewise, polymeric or thin metal valves can also be used. Additionally, alternative exemplary replacement valves of the type described in the aforementioned US Patent Nos. 6,719,789 and 5,480,424 to Cox may also be used. Also, the above descriptions should be considered as illustrative and not restrictive.

已参照几个实施例说明了本发明。本文所引任何专利、专利申请、出版和杂志论文均全文结合于此以供参考。前述详细说明和示例仅为清晰理解给出。其中不应理解有任何不必要的限制。对于本领域技术人员,很明显可对所述实施例做出许多改变而不背离本发明的范围。因此,本发明的范围不应限于本文所述结构,而仅由权利要求语言所述结构及其等效结构限制。The invention has been described with reference to several embodiments. Any patents, patent applications, publications and journal articles cited herein are hereby incorporated by reference in their entirety. The foregoing detailed description and examples have been given for clarity of understanding only. No unnecessary limitations should be understood therein. It will be apparent to those skilled in the art that many changes can be made to the described embodiments without departing from the scope of the invention. Thus, the scope of the present invention should not be limited to the structures described herein, but only by structures described by the language of the claims and the equivalents thereof.

Claims (8)

  1. One kind be used to place valve in diameter greater than the equipment in the pipe of this valve diameter, this equipment comprises:
    Adapter; Said adapter comprise by the cylindrical outer wall with first diameter around enclosed volume; This cylindrical outer wall and concentric the separating of cylinder shape inner wall that has less than second diameter of said first diameter; First end wall and second end wall extend the near-end and the far-end of the said adapter between said cylindrical outer wall and the said cylinder shape inner wall respectively, and stretch out on the surface of at least one from said cylindrical outer wall and said cylinder shape inner wall of at least one integrally formed convexity;
    A certain amount of material that comprises in the said enclosed volume;
    Be installed on the interior valve of cylinder shape inner wall of said adapter.
  2. 2. equipment as claimed in claim 1, wherein cylindrical outer wall and cylinder shape inner wall and extend said cylindrical outer wall and said cylinder shape inner wall between said first end wall and said second end wall comprise anti-liquid material.
  3. 3. equipment as claimed in claim 1, contained material is a fluent material in the wherein said enclosed volume.
  4. 4. equipment as claimed in claim 1, contained material is a gel rubber material in the wherein said enclosed volume.
  5. 5. equipment as claimed in claim 1, contained material is at least semisolid in the wherein said enclosed volume.
  6. 6. equipment as claimed in claim 1, wherein said cylindrical outer wall comprise at least one convexity that is away from the central longitudinal axis of said equipment from this cylindrical outer wall surface and stretches out.
  7. 7. equipment as claimed in claim 1, wherein said cylinder shape inner wall comprise from this cylindrical inner wall surfaces towards the central longitudinal axis of said equipment and at least one convexity of stretching out.
  8. 8. equipment as claimed in claim 7, wherein said at least one integrally formed convexity comprises a plurality of convexity spaced apart from each other.
CN2007800173920A 2006-04-28 2007-04-27 Apparatus for cardiac valve replacement Expired - Fee Related CN101442958B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US79580206P 2006-04-28 2006-04-28
US60/795,802 2006-04-28
PCT/US2007/010348 WO2007127433A2 (en) 2006-04-28 2007-04-27 Method and apparatus for cardiac valve replacement

Publications (2)

Publication Number Publication Date
CN101442958A CN101442958A (en) 2009-05-27
CN101442958B true CN101442958B (en) 2012-09-05

Family

ID=38515487

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2007800173920A Expired - Fee Related CN101442958B (en) 2006-04-28 2007-04-27 Apparatus for cardiac valve replacement

Country Status (4)

Country Link
US (3) US20070255394A1 (en)
EP (1) EP2023859B1 (en)
CN (1) CN101442958B (en)
WO (1) WO2007127433A2 (en)

Families Citing this family (194)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6006134A (en) 1998-04-30 1999-12-21 Medtronic, Inc. Method and device for electronically controlling the beating of a heart using venous electrical stimulation of nerve fibers
US8579966B2 (en) 1999-11-17 2013-11-12 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
US8016877B2 (en) 1999-11-17 2011-09-13 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
US7018406B2 (en) 1999-11-17 2006-03-28 Corevalve Sa Prosthetic valve for transluminal delivery
US8241274B2 (en) 2000-01-19 2012-08-14 Medtronic, Inc. Method for guiding a medical device
US7749245B2 (en) 2000-01-27 2010-07-06 Medtronic, Inc. Cardiac valve procedure methods and devices
WO2002005888A1 (en) 2000-06-30 2002-01-24 Viacor Incorporated Intravascular filter with debris entrapment mechanism
US7544206B2 (en) 2001-06-29 2009-06-09 Medtronic, Inc. Method and apparatus for resecting and replacing an aortic valve
US8771302B2 (en) 2001-06-29 2014-07-08 Medtronic, Inc. Method and apparatus for resecting and replacing an aortic valve
US8623077B2 (en) 2001-06-29 2014-01-07 Medtronic, Inc. Apparatus for replacing a cardiac valve
FR2826863B1 (en) 2001-07-04 2003-09-26 Jacques Seguin ASSEMBLY FOR PLACING A PROSTHETIC VALVE IN A BODY CONDUIT
FR2828091B1 (en) 2001-07-31 2003-11-21 Seguin Jacques ASSEMBLY ALLOWING THE PLACEMENT OF A PROTHETIC VALVE IN A BODY DUCT
US7097659B2 (en) 2001-09-07 2006-08-29 Medtronic, Inc. Fixation band for affixing a prosthetic heart valve to tissue
CA2462509A1 (en) 2001-10-04 2003-04-10 Neovasc Medical Ltd. Flow reducing implant
ATE481057T1 (en) * 2003-05-28 2010-10-15 Cook Inc VALVE PROSTHESIS WITH VESSEL FIXING DEVICE
US9579194B2 (en) 2003-10-06 2017-02-28 Medtronic ATS Medical, Inc. Anchoring structure with concave landing zone
IL158960A0 (en) 2003-11-19 2004-05-12 Neovasc Medical Ltd Vascular implant
ITTO20040135A1 (en) 2004-03-03 2004-06-03 Sorin Biomedica Cardio Spa CARDIAC VALVE PROSTHESIS
WO2005102015A2 (en) 2004-04-23 2005-11-03 3F Therapeutics, Inc. Implantable prosthetic valve
US20060052867A1 (en) 2004-09-07 2006-03-09 Medtronic, Inc Replacement prosthetic heart valve, system and method of implant
US7704277B2 (en) 2004-09-14 2010-04-27 Edwards Lifesciences Ag Device and method for treatment of heart valve regurgitation
EP2481375A3 (en) * 2004-10-02 2013-12-04 Endoheart AG Devices for delivery and removal of heart valves
US8562672B2 (en) 2004-11-19 2013-10-22 Medtronic, Inc. Apparatus for treatment of cardiac valves and method of its manufacture
DE102005003632A1 (en) 2005-01-20 2006-08-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Catheter for the transvascular implantation of heart valve prostheses
ITTO20050074A1 (en) 2005-02-10 2006-08-11 Sorin Biomedica Cardio Srl CARDIAC VALVE PROSTHESIS
US7914569B2 (en) 2005-05-13 2011-03-29 Medtronics Corevalve Llc Heart valve prosthesis and methods of manufacture and use
US20070078510A1 (en) 2005-09-26 2007-04-05 Ryan Timothy R Prosthetic cardiac and venous valves
US9265605B2 (en) * 2005-10-14 2016-02-23 Boston Scientific Scimed, Inc. Bronchoscopic lung volume reduction valve
US8038720B2 (en) * 2005-10-18 2011-10-18 Wallace Jeffrey M Methods and devices for intragastrointestinal prostheses
CA2629534C (en) 2005-11-10 2015-02-24 Arshad Quadri Balloon-expandable, self-expanding, vascular prosthesis connecting stent
US8075615B2 (en) 2006-03-28 2011-12-13 Medtronic, Inc. Prosthetic cardiac valve formed from pericardium material and methods of making same
WO2008013915A2 (en) 2006-07-28 2008-01-31 Arshad Quadri Percutaneous valve prosthesis and system and method for implanting same
US8876895B2 (en) 2006-09-19 2014-11-04 Medtronic Ventor Technologies Ltd. Valve fixation member having engagement arms
US11304800B2 (en) 2006-09-19 2022-04-19 Medtronic Ventor Technologies Ltd. Sinus-engaging valve fixation member
US8834564B2 (en) 2006-09-19 2014-09-16 Medtronic, Inc. Sinus-engaging valve fixation member
WO2008047354A2 (en) 2006-10-16 2008-04-24 Ventor Technologies Ltd. Transapical delivery system with ventriculo-arterial overflow bypass
WO2008070797A2 (en) 2006-12-06 2008-06-12 Medtronic Corevalve, Inc. System and method for transapical delivery of an annulus anchored self-expanding valve
US9504568B2 (en) 2007-02-16 2016-11-29 Medtronic, Inc. Replacement prosthetic heart valves and methods of implantation
US7896915B2 (en) 2007-04-13 2011-03-01 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
FR2915087B1 (en) 2007-04-20 2021-11-26 Corevalve Inc IMPLANT FOR TREATMENT OF A HEART VALVE, IN PARTICULAR OF A MITRAL VALVE, EQUIPMENT INCLUDING THIS IMPLANT AND MATERIAL FOR PLACING THIS IMPLANT.
FR2916627B1 (en) * 2007-05-30 2010-09-17 Perouse Lab NECESSARY FOR TREATING A BLOOD CIRCULATION CONDUIT
US8747458B2 (en) 2007-08-20 2014-06-10 Medtronic Ventor Technologies Ltd. Stent loading tool and method for use thereof
FR2932376B1 (en) * 2008-06-11 2011-04-01 Perouse Lab DEVICE FOR TREATING A BLOOD CIRCULATION CONDUIT
US10856970B2 (en) 2007-10-10 2020-12-08 Medtronic Ventor Technologies Ltd. Prosthetic heart valve for transfemoral delivery
US9848981B2 (en) 2007-10-12 2017-12-26 Mayo Foundation For Medical Education And Research Expandable valve prosthesis with sealing mechanism
US8303650B2 (en) * 2008-01-10 2012-11-06 Telesis Research, Llc Biodegradable self-expanding drug-eluting prosthesis
US8317857B2 (en) * 2008-01-10 2012-11-27 Telesis Research, Llc Biodegradable self-expanding prosthesis
EP3572045B1 (en) 2008-01-24 2022-12-21 Medtronic, Inc. Stents for prosthetic heart valves
US9089422B2 (en) 2008-01-24 2015-07-28 Medtronic, Inc. Markers for prosthetic heart valves
US8157853B2 (en) 2008-01-24 2012-04-17 Medtronic, Inc. Delivery systems and methods of implantation for prosthetic heart valves
US9149358B2 (en) 2008-01-24 2015-10-06 Medtronic, Inc. Delivery systems for prosthetic heart valves
US9393115B2 (en) 2008-01-24 2016-07-19 Medtronic, Inc. Delivery systems and methods of implantation for prosthetic heart valves
WO2009094197A1 (en) 2008-01-24 2009-07-30 Medtronic, Inc. Stents for prosthetic heart valves
CN101951858B (en) 2008-02-25 2015-02-11 麦德托尼克瓦斯科尔勒公司 Infundibular reducer devices
WO2011104269A1 (en) 2008-02-26 2011-09-01 Jenavalve Technology Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US9044318B2 (en) 2008-02-26 2015-06-02 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis
WO2009108355A1 (en) 2008-02-28 2009-09-03 Medtronic, Inc. Prosthetic heart valve systems
US8313525B2 (en) 2008-03-18 2012-11-20 Medtronic Ventor Technologies, Ltd. Valve suturing and implantation procedures
US8430927B2 (en) 2008-04-08 2013-04-30 Medtronic, Inc. Multiple orifice implantable heart valve and methods of implantation
US8696743B2 (en) 2008-04-23 2014-04-15 Medtronic, Inc. Tissue attachment devices and methods for prosthetic heart valves
US8312825B2 (en) 2008-04-23 2012-11-20 Medtronic, Inc. Methods and apparatuses for assembly of a pericardial prosthetic heart valve
US20090276040A1 (en) 2008-05-01 2009-11-05 Edwards Lifesciences Corporation Device and method for replacing mitral valve
EP2119417B2 (en) 2008-05-16 2020-04-29 Sorin Group Italia S.r.l. Atraumatic prosthetic heart valve prosthesis
WO2009152470A1 (en) 2008-06-13 2009-12-17 The Foundry, Llc. Methods and apparatus for joint distraction
US8974462B2 (en) * 2008-06-13 2015-03-10 Pivot Medical, Inc. Devices and methods for minimally invasive access into a joint
WO2010031060A1 (en) 2008-09-15 2010-03-18 Medtronic Ventor Technologies Ltd. Prosthetic heart valve having identifiers for aiding in radiographic positioning
US8721714B2 (en) 2008-09-17 2014-05-13 Medtronic Corevalve Llc Delivery system for deployment of medical devices
AU2009295960A1 (en) 2008-09-29 2010-04-01 Cardiaq Valve Technologies, Inc. Heart valve
EP2341871B1 (en) 2008-10-01 2017-03-22 Edwards Lifesciences CardiAQ LLC Delivery system for vascular implant
US8137398B2 (en) 2008-10-13 2012-03-20 Medtronic Ventor Technologies Ltd Prosthetic valve having tapered tip when compressed for delivery
US8986361B2 (en) 2008-10-17 2015-03-24 Medtronic Corevalve, Inc. Delivery system for deployment of medical devices
EP2682072A1 (en) 2008-12-23 2014-01-08 Sorin Group Italia S.r.l. Expandable prosthetic valve having anchoring appendages
US10426453B2 (en) 2009-03-17 2019-10-01 Pivot Medical, Inc. Method and apparatus for distracting a joint
CA2754905A1 (en) * 2009-03-17 2010-09-23 Pivot Medical, Inc. Method and apparatus for distracting a joint, including the provision and use of a novel joint-spacing balloon catheter and a novel inflatable perineal post
US12035902B2 (en) 2009-03-17 2024-07-16 Stryker Corporation Method and apparatus for distracting a joint
US9186181B2 (en) 2009-03-17 2015-11-17 Pivot Medical, Inc. Method and apparatus for distracting a joint
EP4119098A1 (en) 2009-04-15 2023-01-18 Edwards Lifesciences CardiAQ LLC Vascular implant and delivery system
EP2246011B1 (en) 2009-04-27 2014-09-03 Sorin Group Italia S.r.l. Prosthetic vascular conduit
EP4035623A1 (en) 2009-04-29 2022-08-03 Edwards Lifesciences Corporation Apparatus and method for replacing a diseased cardiac valve
US8075611B2 (en) 2009-06-02 2011-12-13 Medtronic, Inc. Stented prosthetic heart valves
US9730790B2 (en) 2009-09-29 2017-08-15 Edwards Lifesciences Cardiaq Llc Replacement valve and method
US8808369B2 (en) 2009-10-05 2014-08-19 Mayo Foundation For Medical Education And Research Minimally invasive aortic valve replacement
US8721649B2 (en) 2009-12-04 2014-05-13 Pivot Medical, Inc. Hip joint access using a circumferential wire and balloon
US8449599B2 (en) 2009-12-04 2013-05-28 Edwards Lifesciences Corporation Prosthetic valve for replacing mitral valve
US9089314B2 (en) * 2010-01-27 2015-07-28 Medtronic Cryocath Lp Partially compliant balloon device
US20130211489A1 (en) * 2010-02-10 2013-08-15 Apertomed L.L.C. Methods, Systems and Devices for Treatment of Cerebrospinal Venous Insufficiency and Multiple Sclerosis
US9226826B2 (en) 2010-02-24 2016-01-05 Medtronic, Inc. Transcatheter valve structure and methods for valve delivery
US8652204B2 (en) 2010-04-01 2014-02-18 Medtronic, Inc. Transcatheter valve with torsion spring fixation and related systems and methods
US8579964B2 (en) 2010-05-05 2013-11-12 Neovasc Inc. Transcatheter mitral valve prosthesis
US10856978B2 (en) 2010-05-20 2020-12-08 Jenavalve Technology, Inc. Catheter system
IT1400327B1 (en) 2010-05-21 2013-05-24 Sorin Biomedica Cardio Srl SUPPORT DEVICE FOR VALVULAR PROSTHESIS AND CORRESPONDING CORRESPONDENT.
JP2013526388A (en) 2010-05-25 2013-06-24 イエナバルブ テクノロジー インク Artificial heart valve, and transcatheter delivery prosthesis comprising an artificial heart valve and a stent
CA2803149C (en) 2010-06-21 2018-08-14 Impala, Inc. Replacement heart valve
WO2012015825A2 (en) 2010-07-27 2012-02-02 Incept, Llc Methods and apparatus for treating neurovascular venous outflow obstruction
AU2011296361B2 (en) 2010-09-01 2015-05-28 Medtronic Vascular Galway Prosthetic valve support structure
US8641757B2 (en) * 2010-09-10 2014-02-04 Edwards Lifesciences Corporation Systems for rapidly deploying surgical heart valves
WO2012040655A2 (en) 2010-09-23 2012-03-29 Cardiaq Valve Technologies, Inc. Replacement heart valves, delivery devices and methods
CN103458954A (en) 2010-11-08 2013-12-18 皮沃特医疗公司 Method and device for stretching a joint
EP2478870A1 (en) * 2011-01-24 2012-07-25 Biotronik AG Medical valve implant, in particular heart valve implant, for implantation in an animal body and/or human body
ES2641902T3 (en) 2011-02-14 2017-11-14 Sorin Group Italia S.R.L. Sutureless anchoring device for cardiac valve prostheses
EP2486894B1 (en) 2011-02-14 2021-06-09 Sorin Group Italia S.r.l. Sutureless anchoring device for cardiac valve prostheses
US9554897B2 (en) 2011-04-28 2017-01-31 Neovasc Tiara Inc. Methods and apparatus for engaging a valve prosthesis with tissue
US9308087B2 (en) 2011-04-28 2016-04-12 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
US10238483B2 (en) 2011-09-16 2019-03-26 3Dt Holdings, Llc Devices and methods for assisting valve function, replacing venous valves, and predicting valve treatment success
ES2523223T3 (en) 2011-12-29 2014-11-24 Sorin Group Italia S.R.L. A kit for the implantation of prosthetic vascular ducts
US9345573B2 (en) 2012-05-30 2016-05-24 Neovasc Tiara Inc. Methods and apparatus for loading a prosthesis onto a delivery system
US9883941B2 (en) 2012-06-19 2018-02-06 Boston Scientific Scimed, Inc. Replacement heart valve
US9439763B2 (en) 2013-02-04 2016-09-13 Edwards Lifesciences Corporation Prosthetic valve for replacing mitral valve
US10583002B2 (en) 2013-03-11 2020-03-10 Neovasc Tiara Inc. Prosthetic valve with anti-pivoting mechanism
ES2824628T3 (en) * 2013-03-14 2021-05-12 Valve Medical Ltd Temporary valve
US9730791B2 (en) 2013-03-14 2017-08-15 Edwards Lifesciences Cardiaq Llc Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery
US9681951B2 (en) 2013-03-14 2017-06-20 Edwards Lifesciences Cardiaq Llc Prosthesis with outer skirt and anchors
US20140277427A1 (en) 2013-03-14 2014-09-18 Cardiaq Valve Technologies, Inc. Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery
US11224510B2 (en) 2013-04-02 2022-01-18 Tendyne Holdings, Inc. Prosthetic heart valve and systems and methods for delivering the same
US10463489B2 (en) 2013-04-02 2019-11-05 Tendyne Holdings, Inc. Prosthetic heart valve and systems and methods for delivering the same
US10478293B2 (en) 2013-04-04 2019-11-19 Tendyne Holdings, Inc. Retrieval and repositioning system for prosthetic heart valve
US9572665B2 (en) 2013-04-04 2017-02-21 Neovasc Tiara Inc. Methods and apparatus for delivering a prosthetic valve to a beating heart
WO2014179763A1 (en) 2013-05-03 2014-11-06 Medtronic Inc. Valve delivery tool
US9867694B2 (en) 2013-08-30 2018-01-16 Jenavalve Technology Inc. Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame
CN108403261B (en) 2013-10-28 2021-02-12 坦迪尼控股股份有限公司 Prosthetic heart valves and systems and methods for delivering prosthetic heart valves
WO2015127283A1 (en) 2014-02-21 2015-08-27 Cardiaq Valve Technologies, Inc. Delivery device for controlled deployement of a replacement valve
USD755384S1 (en) 2014-03-05 2016-05-03 Edwards Lifesciences Cardiaq Llc Stent
WO2015179423A1 (en) 2014-05-19 2015-11-26 Cardiaq Valve Technologies, Inc. Replacement mitral valve with annular flap
US9532870B2 (en) 2014-06-06 2017-01-03 Edwards Lifesciences Corporation Prosthetic valve for replacing a mitral valve
EP3197397B1 (en) 2014-09-28 2021-01-13 Cardiokinetix, Inc. Apparatuses for treating cardiac dysfunction
ES2989081T3 (en) 2014-11-26 2024-11-25 Edwards Lifesciences Corp Transcatheter prosthetic heart valve and delivery system
EP3725243A1 (en) 2015-03-20 2020-10-21 Cardiokinetix, Inc. Methods for preparing the delivery of an implantable device
EP3730094B1 (en) 2015-03-20 2024-04-24 JenaValve Technology, Inc. Heart valve prosthesis delivery system
US10441416B2 (en) 2015-04-21 2019-10-15 Edwards Lifesciences Corporation Percutaneous mitral valve replacement device
US10376363B2 (en) 2015-04-30 2019-08-13 Edwards Lifesciences Cardiaq Llc Replacement mitral valve, delivery system for replacement mitral valve and methods of use
EP3632378B1 (en) 2015-05-01 2024-05-29 JenaValve Technology, Inc. Device with reduced pacemaker rate in heart valve replacement
US10226335B2 (en) 2015-06-22 2019-03-12 Edwards Lifesciences Cardiaq Llc Actively controllable heart valve implant and method of controlling same
US10092400B2 (en) 2015-06-23 2018-10-09 Edwards Lifesciences Cardiaq Llc Systems and methods for anchoring and sealing a prosthetic heart valve
US10575951B2 (en) 2015-08-26 2020-03-03 Edwards Lifesciences Cardiaq Llc Delivery device and methods of use for transapical delivery of replacement mitral valve
US10117744B2 (en) 2015-08-26 2018-11-06 Edwards Lifesciences Cardiaq Llc Replacement heart valves and methods of delivery
US10350066B2 (en) 2015-08-28 2019-07-16 Edwards Lifesciences Cardiaq Llc Steerable delivery system for replacement mitral valve and methods of use
EP4112006A1 (en) 2015-12-15 2023-01-04 Neovasc Tiara Inc. Transseptal delivery system
CN108882981B (en) 2016-01-29 2021-08-10 内奥瓦斯克迪亚拉公司 Prosthetic valve for preventing outflow obstruction
USD815744S1 (en) 2016-04-28 2018-04-17 Edwards Lifesciences Cardiaq Llc Valve frame for a delivery system
JP7081749B2 (en) 2016-05-13 2022-06-07 イエナバルブ テクノロジー インク Heart valve prosthesis delivery system
CN113243957B (en) 2016-05-16 2024-12-27 瓣膜医学有限公司 Inverted temporary valve sheath
US10350062B2 (en) 2016-07-21 2019-07-16 Edwards Lifesciences Corporation Replacement heart valve prosthesis
CN109789017B (en) 2016-08-19 2022-05-31 爱德华兹生命科学公司 Steerable delivery system for replacing a mitral valve and methods of use
AU2017314852B2 (en) 2016-08-26 2022-06-30 Edwards Lifesciences Corporation Multi-portion replacement heart valve prosthesis
US10758348B2 (en) 2016-11-02 2020-09-01 Edwards Lifesciences Corporation Supra and sub-annular mitral valve delivery system
WO2018089557A1 (en) * 2016-11-09 2018-05-17 Boston Scientific Scimed, Inc. Stent including displacement capabilities
CN113893064A (en) 2016-11-21 2022-01-07 内奥瓦斯克迪亚拉公司 Methods and systems for rapid retrieval of transcatheter heart valve delivery systems
US11197754B2 (en) 2017-01-27 2021-12-14 Jenavalve Technology, Inc. Heart valve mimicry
CN107334545A (en) * 2017-03-08 2017-11-10 上海威宁整形制品有限公司 Perforator flap expander with PTFE coating and manufacturing method thereof
CN110996855B (en) 2017-07-06 2022-05-06 爱德华兹生命科学公司 Steerable Rail Delivery System
EP3661568A4 (en) * 2017-08-03 2021-04-14 Ortho-Space Ltd. SELF-HEALING BALLOONS
CN111263622A (en) 2017-08-25 2020-06-09 内奥瓦斯克迪亚拉公司 Sequentially deployed transcatheter mitral valve prosthesis
US12144540B2 (en) * 2017-10-27 2024-11-19 St. Jude Medical, Cardiology Division, Inc. Pulmonary vein isolation balloon catheter
WO2019147846A2 (en) 2018-01-25 2019-08-01 Edwards Lifesciences Corporation Delivery system for aided replacement valve recapture and repositioning post- deployment
US11051934B2 (en) 2018-02-28 2021-07-06 Edwards Lifesciences Corporation Prosthetic mitral valve with improved anchors and seal
WO2019195860A2 (en) 2018-04-04 2019-10-10 Vdyne, Llc Devices and methods for anchoring transcatheter heart valve
AU2018424863B2 (en) 2018-05-23 2024-07-11 Corcym S.R.L. A device for in-situ delivery Of heart valve prostheses
US11504231B2 (en) 2018-05-23 2022-11-22 Corcym S.R.L. Cardiac valve prosthesis
JP7138928B2 (en) * 2018-08-22 2022-09-20 株式会社サンメディカル技術研究所 Aortic valve assessment aid
US12186187B2 (en) 2018-09-20 2025-01-07 Vdyne, Inc. Transcatheter deliverable prosthetic heart valves and methods of delivery
US10321995B1 (en) 2018-09-20 2019-06-18 Vdyne, Llc Orthogonally delivered transcatheter heart valve replacement
US11278437B2 (en) 2018-12-08 2022-03-22 Vdyne, Inc. Compression capable annular frames for side delivery of transcatheter heart valve replacement
US11071627B2 (en) 2018-10-18 2021-07-27 Vdyne, Inc. Orthogonally delivered transcatheter heart valve frame for valve in valve prosthesis
US10595994B1 (en) 2018-09-20 2020-03-24 Vdyne, Llc Side-delivered transcatheter heart valve replacement
US11344413B2 (en) 2018-09-20 2022-05-31 Vdyne, Inc. Transcatheter deliverable prosthetic heart valves and methods of delivery
US11109969B2 (en) 2018-10-22 2021-09-07 Vdyne, Inc. Guidewire delivery of transcatheter heart valve
EP3876870B1 (en) 2018-11-08 2023-12-20 Neovasc Tiara Inc. Ventricular deployment of a transcatheter mitral valve prosthesis
WO2020117562A1 (en) * 2018-12-04 2020-06-11 The Brain Protection Company PTY LTD Combinatorial therapies including implantable damping devices and therapeutic agents for treating a condition and associated systems and methods of use
US10653522B1 (en) 2018-12-20 2020-05-19 Vdyne, Inc. Proximal tab for side-delivered transcatheter heart valve prosthesis
US11253359B2 (en) 2018-12-20 2022-02-22 Vdyne, Inc. Proximal tab for side-delivered transcatheter heart valves and methods of delivery
WO2020146842A1 (en) 2019-01-10 2020-07-16 Vdyne, Llc Anchor hook for side-delivery transcatheter heart valve prosthesis
EP3914165B1 (en) 2019-01-23 2024-08-14 Shockwave Medical, Inc. Covered flow modifying apparatus
US11273032B2 (en) 2019-01-26 2022-03-15 Vdyne, Inc. Collapsible inner flow control component for side-deliverable transcatheter heart valve prosthesis
US11185409B2 (en) 2019-01-26 2021-11-30 Vdyne, Inc. Collapsible inner flow control component for side-delivered transcatheter heart valve prosthesis
CN120899433A (en) 2019-03-05 2025-11-07 维迪内股份有限公司 Tricuspid regurgitation control device for orthorhombic transcatheter heart valve prostheses
WO2020185597A1 (en) 2019-03-08 2020-09-17 Neovasc Tiara Inc. Retrievable prosthesis delivery system
US10631983B1 (en) 2019-03-14 2020-04-28 Vdyne, Inc. Distal subannular anchoring tab for side-delivered transcatheter valve prosthesis
US11173027B2 (en) 2019-03-14 2021-11-16 Vdyne, Inc. Side-deliverable transcatheter prosthetic valves and methods for delivering and anchoring the same
US10758346B1 (en) 2019-03-14 2020-09-01 Vdyne, Inc. A2 clip for side-delivered transcatheter mitral valve prosthesis
US11076956B2 (en) 2019-03-14 2021-08-03 Vdyne, Inc. Proximal, distal, and anterior anchoring tabs for side-delivered transcatheter mitral valve prosthesis
WO2020206012A1 (en) 2019-04-01 2020-10-08 Neovasc Tiara Inc. Controllably deployable prosthetic valve
WO2020210652A1 (en) 2019-04-10 2020-10-15 Neovasc Tiara Inc. Prosthetic valve with natural blood flow
JP7381601B2 (en) 2019-04-12 2023-11-15 エドワーズ ライフサイエンシーズ コーポレイション Valves with multi-part frames and associated resilient bridge features
CA3137105A1 (en) 2019-04-23 2020-10-29 Edwards Lifesciences Corporation Motorized implant delivery system
CN120827457A (en) 2019-05-04 2025-10-24 维迪内股份有限公司 Lacing devices and methods for deploying a side-delivered prosthetic heart valve in a native annulus
CN114025813B (en) 2019-05-20 2024-05-14 内奥瓦斯克迪亚拉公司 Introducer with hemostatic mechanism
WO2020257643A1 (en) 2019-06-20 2020-12-24 Neovasc Tiara Inc. Low profile prosthetic mitral valve
WO2021035032A1 (en) 2019-08-20 2021-02-25 Vdyne, Inc. Delivery and retrieval devices and methods for side-deliverable transcatheter prosthetic valves
CN114630665B (en) 2019-08-26 2025-06-17 维迪内股份有限公司 Laterally deliverable transcatheter prosthetic valve and method of delivering and anchoring the same
CN112641544B (en) * 2019-10-09 2024-09-17 奥林巴斯株式会社 Bracket device
US11234813B2 (en) 2020-01-17 2022-02-01 Vdyne, Inc. Ventricular stability elements for side-deliverable prosthetic heart valves and methods of delivery
US11786355B2 (en) 2020-01-30 2023-10-17 Boston Scientific Scimed, Inc. Radial adjusting self-expanding stent with anti-migration features
EP4247297A1 (en) 2020-12-18 2023-09-27 Edwards Lifesciences Corporation Storage jar assembly for aprosthetic heart valve
US12171658B2 (en) 2022-11-09 2024-12-24 Jenavalve Technology, Inc. Catheter system for sequential deployment of an expandable implant

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5980570A (en) * 1998-03-27 1999-11-09 Sulzer Carbomedics Inc. System and method for implanting an expandable medical device into a body
CN2505045Y (en) * 2001-08-22 2002-08-14 董春明 Artificial mechanism heart valves

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0850607A1 (en) * 1996-12-31 1998-07-01 Cordis Corporation Valve prosthesis for implantation in body channels
GB0114918D0 (en) * 2001-06-19 2001-08-08 Vortex Innovation Ltd Devices for repairing aneurysms
FR2826863B1 (en) * 2001-07-04 2003-09-26 Jacques Seguin ASSEMBLY FOR PLACING A PROSTHETIC VALVE IN A BODY CONDUIT
US20030199971A1 (en) * 2002-04-23 2003-10-23 Numed, Inc. Biological replacement valve assembly
EG24012A (en) * 2003-09-24 2008-03-23 Wael Mohamed Nabil Lotfy Valved balloon stent
US8128681B2 (en) * 2003-12-19 2012-03-06 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US7641686B2 (en) * 2004-04-23 2010-01-05 Direct Flow Medical, Inc. Percutaneous heart valve with stentless support
JP5227588B2 (en) * 2004-05-05 2013-07-03 ダイレクト フロウ メディカル、 インク. Stentless heart valve with in situ formed support structure
US8562672B2 (en) * 2004-11-19 2013-10-22 Medtronic, Inc. Apparatus for treatment of cardiac valves and method of its manufacture
US20060178731A1 (en) * 2005-02-09 2006-08-10 Numed, Inc. Apparatus for aiding the flow of blood through patient's circulatory system
US7331991B2 (en) * 2005-02-25 2008-02-19 California Institute Of Technology Implantable small percutaneous valve and methods of delivery
EP3292838A1 (en) * 2005-05-24 2018-03-14 Edwards Lifesciences Corporation Rapid deployment prosthetic heart valve
US8663312B2 (en) * 2005-05-27 2014-03-04 Hlt, Inc. Intravascular cuff
FR2906454B1 (en) * 2006-09-28 2009-04-10 Perouse Soc Par Actions Simpli IMPLANT INTENDED TO BE PLACED IN A BLOOD CIRCULATION CONDUIT.
US8133270B2 (en) * 2007-01-08 2012-03-13 California Institute Of Technology In-situ formation of a valve
EP2109417B1 (en) * 2007-02-05 2013-11-06 Boston Scientific Limited Percutaneous valve and delivery system
US8795354B2 (en) * 2010-03-05 2014-08-05 Edwards Lifesciences Corporation Low-profile heart valve and delivery system
AU2013214782B2 (en) * 2012-02-01 2017-03-09 Hlt, Inc. Invertible tissue valve and method

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5980570A (en) * 1998-03-27 1999-11-09 Sulzer Carbomedics Inc. System and method for implanting an expandable medical device into a body
CN2505045Y (en) * 2001-08-22 2002-08-14 董春明 Artificial mechanism heart valves

Also Published As

Publication number Publication date
EP2023859B1 (en) 2012-12-26
EP2023859A2 (en) 2009-02-18
US20070255394A1 (en) 2007-11-01
WO2007127433A3 (en) 2008-02-07
US20170333184A1 (en) 2017-11-23
US20230000620A1 (en) 2023-01-05
CN101442958A (en) 2009-05-27
WO2007127433A2 (en) 2007-11-08

Similar Documents

Publication Publication Date Title
US20230000620A1 (en) Method and apparatus for cardiac valve replacement
US20250032108A1 (en) Devices and methods for delivery of expandable prostheses
US10813759B2 (en) Two component mitral valve
US8070800B2 (en) Transcatheter heart valve prostheses
EP1765225B1 (en) Paravalvular leak detection, sealing and prevention
AU2005213458B2 (en) Transcatheter delivery of a replacement heart valve
EP2900177B1 (en) Systems for replacing a native heart valve and aorta with a prosthetic heart valve and conduit
CA2588140C (en) Method and apparatus for treatment of cardiac valves
US7524331B2 (en) Catheter delivered valve having a barrier to provide an enhanced seal
CN115461017A (en) Balloon expandable heart valve system and method of implantation
RU223045U1 (en) Balloon-expandable aortic heart valve prosthesis for seamless implantation
HK40023102B (en) Systems for replacing a native heart valve and repairing an aorta with a prosthetic heart valve and conduit

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120905

CF01 Termination of patent right due to non-payment of annual fee